STAT3 and neoplasm: This study showed that treatment with ubenimex alone or combined with pemetrexed could considerably increase the expression level of SOCS1 in patients' serum, lung adenocarcinoma cells, and mouse tumor tissues and inhibit the JAK2/STAT3 signaling pathway.